Business
First Welsh adopter of Speedboat® technology
First Welsh adopter of Speedboat® technology.
About this update from Creo Medical Group Plc
[{"type":"text","content":"\n\nCreo Medical Group plc\n(\"Creo\" the \"Company\" or the \"Group\")\n \nFirst Welsh adopter of Speedboat® technology for colon cancer\n \nAneurin Bevan University Health Board initiates Speedboat® pilot \n \nCreo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces that the Aneurin Bevan University Health Board (\"ABUHB\") has initiated a six-month pilot of Creo's Speedboat® technology, becoming the first Health Board in Wales to implement the technology.\n \nThe news has been announced by ABUHB online and is available to view via the following link.\n \nhttps://abuhb.nhs.wales/news/news/aneurin-bevan-university-health-board-leads-the-way-in-wales-with-innovative-speedboat-device-to-tackle-colon-cancer/\n \nThe full text is reproduced below:\n \nAneurin Bevan University Health Board Leads the Way in Wales\nwith Innovative Speedboat Device to Tackle Colon Cancer\n \nAneurin Bevan University Health Board (ABUHB) has become the first in Wales to pilot the groundbreaking Speedboat Submucosal Dissection (SSD) technology, transforming the treatment pathway for patients with complex colorectal polyps. Developed by Welsh med-tech company Creo Medical, this innovative device offers a minimally invasive alternative to traditional surgery, significantly improving patient outcomes and recovery times.\n \nCurrently, patients with complex polyps often face multiple procedures or major surgery, which can result in lengthy recovery times and higher risks. The Speedboat device allows clinicians to perform a single, minimally invasive procedure to remove polyps effectively, reducing the need for surgery and enabling faster patient recovery. Introducing this technology addresses a critical gap in treatment services in Wales.\n \nDr. Alka Joshi, Clinical Lead for the pilot, commented: \"This pilot is a significant step forward for our patients. By utilising the Speedboat device, we can offer a more efficient, less invasive alternative to traditional surgical methods, improving outcomes and reducing waiting times.\"\n \nSince the pilot's launch before Christmas, three patients have undergone the treatment successfully with no recorded complications. Each procedur...